Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)

Market Cap	22.37B
Revenue (ttm)	2.37B
Net Income (ttm)	1.92B
Shares Out	1.17B
EPS (ttm)	1.62
PE Ratio	11.80
Forward PE	n/a
Dividend	0.60 (3.11%)
Ex-Dividend Date	Jul 9, 2025

Volume	17,448,363
Average Volume	17,122,137
Open	18.33
Previous Close	19.29
Day's Range	18.33 - 19.30
52-Week Range	12.49 - 19.98
Beta	0.60
RSI	81.59
Earnings Date	Aug 30, 2025

About SHE:000623

Jilin Aodong Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China. The company provides various drugs, such as oral liquid solutions, injections, capsules, granules, pills, tablets, Chinese herbal medicines, powders, tonic medicines, syrups, and spirits, as well as enzymes, biochemical medicine, and plant chemical medicine. It is also involved in the highway construction and toll collection businesses; animal husbandry activities; manufacture of specialty chemicals; production and supply of heat...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1957
• Employees: 5,745
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000623

Financial Performance

In 2024, SHE:000623's revenue was 2.61 billion, a decrease of -24.31% compared to the previous year's 3.45 billion. Earnings were 1.55 billion, an increase of 6.27%.